SEC Tracker
Get the app

Addus HomeCare ADUS

Addus HomeCare Q3 FY24: revenue $289.8M, up 7%; diluted EPS $1.10

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Addus HomeCare reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$289.8M+7% from $270.7M in Q3 FY2310-Q income statement, on EDGAR
  2. Net income$20.2M+31% from $15.4M in Q3 FY2310-Q income statement, on EDGAR
  3. Diluted EPS$1.10+16% from $0.95 in Q3 FY2310-Q income statement, on EDGAR
  4. Cash and cash equivalents$222.9M+179% from $79.8M in Q3 FY2310-Q balance sheet, on EDGAR
  5. Cash from operations$48.5M+123% from $21.8M in Q3 FY2310-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Addus HomeCare files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8082 and related industry codes: the same peer list as the financial tables.

  1. BrightSpring Health Services BTSG public float $2.3B, Jun 30, 2025
  2. AdaptHealth AHCO public float $1.0B, Jun 30, 2025
  3. Option Care Health OPCH public float $5.3B, Jun 30, 2025
  4. Chemed CHE public float $7.0B, Jun 30, 2025
  5. Enhabit EHAB public float $480M, Jun 30, 2025